A recent Food and Drug Administration public meeting kicked off a two-month comment period during which stakeholders have been encouraged to share their input on how best to improve generic competition and what current barriers exist.
For the 12 months ended June 2017, the drug had U.S. sales of $122.4 million, according to QuintilesIMS data.
Mylan has invested $250 million in expanding its antiretroviral production capabilities, enabling it to produce 4 billion antiretroviral tablets and capsules each year, the company said.
The drug had U.S. sales of $272 million for the 12 months ended June 2017, according to QuintilesIMS data.
The drug is indicated to treat persistent (nontransient) erythema of rosacea in adults ages 18 years and older.
The bill contains the reauthorizations of the Food and Drug Administration’s Prescription Drug, Biosimilar, and Generic Drug User Fee Acts.
In addition to rolling out new value-focused initiatives, CVS Health said it would be removing 17 drugs from its Standard Control Formulary in 2018
The drug is indicated to relieve inflammatory and pruritic manifestations of dermatoses that are responsive to corticosteroid treatment.
The patch had U.S. sales of approximately $158 million for the 12 months ended May 2017.